{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:17Z","timestamp":1786980077428,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00392-018-1328-x","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T05:21:10Z","timestamp":1532323270000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Percutaneous coronary intervention: balloons, stents and scaffolds"],"prefix":"10.1007","volume":"107","author":[{"given":"Roisin","family":"Colleran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,23]]},"reference":[{"key":"1328_CR1","doi-asserted-by":"publisher","first-page":"64b","DOI":"10.1016\/S0735-1097(97)00558-5","volume":"31","author":"SB King 3rd","year":"1998","unstructured":"King SB 3rd (1998) The development of interventional cardiology. J Am Coll Cardiol 31:64b\u201388b","journal-title":"J Am Coll Cardiol"},{"key":"1328_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1148\/112.3.543","volume":"112","author":"L Wierny","year":"1974","unstructured":"Wierny L, Plass R, Porstmann W (1974) Long-term results in 100 consecutive patients treated by transluminal angioplasty. Radiology 112:543\u2013548","journal-title":"Radiology"},{"key":"1328_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1540-8183.2002.tb01031.x","volume":"15","author":"M Kaltenbach","year":"2002","unstructured":"Kaltenbach M (2002) Evolution of interventional cardiology in Germany. J Interv Cardiol 15:33\u201339","journal-title":"J Interv Cardiol"},{"key":"1328_CR4","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/0002-9149(82)90047-9","volume":"49","author":"JB Simpson","year":"1982","unstructured":"Simpson JB, Baim DS, Robert EW, Harrison DC (1982) A new catheter system for coronary angioplasty. Am J Cardiol 49:1216\u20131222","journal-title":"Am J Cardiol"},{"key":"1328_CR5","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/oxfordjournals.eurheartj.a061601","volume":"5","author":"M Kaltenbach","year":"1984","unstructured":"Kaltenbach M (1984) The long wire technique\u2014a new technique for steerable balloon catheter dilatation of coronary artery stenoses. Eur Heart J 5:1004\u20131009","journal-title":"Eur Heart J"},{"key":"1328_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1515\/bmte.1986.31.9.195","volume":"31","author":"T Bonzel","year":"1986","unstructured":"Bonzel T, Wollschl\u00e4ger H, Just H (1986) A new catheter system for the mechanical dilatation of coronary stenoses with exchangeable intracoronary catheters, fast flow of the contrast agent and improved control. Biomed Tech 31:195\u2013200","journal-title":"Biomed Tech"},{"key":"1328_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0140-6736(17)31927-X","volume":"390","author":"RA Byrne","year":"2017","unstructured":"Byrne RA, Stone GW, Ormiston J, Kastrati A (2017) Coronary balloon angioplasty, stents, and scaffolds. Lancet 390:781\u2013792","journal-title":"Lancet"},{"key":"1328_CR8","first-page":"33203331","volume":"36","author":"RA Byrne","year":"2015","unstructured":"Byrne RA, Joner M, Kastrati A (2015) Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gruntzig Lecture ESC 2014. Eur Heart J 36:3320\u20133331","journal-title":"Eur Heart J"},{"key":"1328_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJM198703193161201","volume":"316","author":"U Sigwart","year":"1987","unstructured":"Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316:701\u2013706","journal-title":"N Engl J Med"},{"key":"1328_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","volume":"346","author":"U Sigwart","year":"1995","unstructured":"Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211\u2013214","journal-title":"Lancet"},{"key":"1328_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1056\/NEJM199408253310801","volume":"331","author":"PW Serruys","year":"1994","unstructured":"Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G et al (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331:489\u2013495","journal-title":"N Engl J Med"},{"key":"1328_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJM199408253310802","volume":"331","author":"DL Fischman","year":"1994","unstructured":"Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I et al (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331:496\u2013501","journal-title":"N Engl J Med"},{"key":"1328_CR13","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","volume":"334","author":"A Schomig","year":"1996","unstructured":"Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M et al (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334:1084\u20131089","journal-title":"N Engl J Med"},{"key":"1328_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/1522-726X(200007)50:3<290::AID-CCD5>3.0.CO;2-W","volume":"50","author":"A Kastrati","year":"2000","unstructured":"Kastrati A, Dirschinger J, Boekstegers P, Elezi S, Schuhlen H, Pache J et al (2000) Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1,147 unselected patients. Catheter Cardiovasc Interv 50:290\u2013297","journal-title":"Catheter Cardiovasc Interv"},{"key":"1328_CR15","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","volume":"123","author":"K Kolandaivelu","year":"2011","unstructured":"Kolandaivelu K, Swaminathan R, Gibson WJ, Kolachalama VB, Nguyen-Ehrenreich KL, Giddings VL et al (2011) Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation 123:1400\u20131409","journal-title":"Circulation"},{"key":"1328_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1615\/JLongTermEffMedImplants.v10.i12.120","volume":"10","author":"C Simon","year":"2000","unstructured":"Simon C, Palmaz JC, Sprague EA (2000) Influence of topography on endothelialization of stents: clues for new designs. J Long Term Effects Med Implants 10:143\u2013151","journal-title":"J Long Term Effects Med Implants"},{"key":"1328_CR17","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1161\/01.CIR.103.23.2816","volume":"103","author":"A Kastrati","year":"2001","unstructured":"Kastrati A, Mehilli J, Dirschinger J, Dotzer F, Schuhlen H, Neumann FJ et al (2001) Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 103:2816\u20132821","journal-title":"Circulation"},{"key":"1328_CR18","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0735-1097(03)00119-0","volume":"41","author":"J Pache","year":"2003","unstructured":"Pache J, Kastrati A, Mehilli J, Schuhlen H, Dotzer F, Hausleiter J et al (2003) Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 41:1283\u20131288","journal-title":"J Am Coll Cardiol"},{"key":"1328_CR19","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1253\/circj.CJ-10-0738","volume":"74","author":"S Schulz","year":"2010","unstructured":"Schulz S, Mehilli J, Schomig A, Kastrati A (2010) ISAR\u2014a story of trials with impact on practice. Circ J 74:1771\u20131778","journal-title":"Circ J"},{"key":"1328_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1051-0443(99)70063-1","volume":"10","author":"JC Palmaz","year":"1999","unstructured":"Palmaz JC, Benson A, Sprague EA (1999) Influence of surface topography on endothelialization of intravascular metallic material. J Vasc Interv Radiol 10:439\u2013444","journal-title":"J Vasc Interv Radiol"},{"key":"1328_CR21","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/1097-4636(20000905)51:3<520::AID-JBM29>3.0.CO;2-A","volume":"51","author":"Y Nakayama","year":"2000","unstructured":"Nakayama Y, Nishi S, Ishibashi-Ueda H, Matsuda T (2000) Surface microarchitectural design in biomedical applications: in vivo analysis of tissue ingrowth in excimer laser-directed micropored scaffold for cardiovascular tissue engineering. J Biomed Mater Res 51:520\u2013528","journal-title":"J Biomed Mater Res"},{"key":"1328_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ccd.20400","volume":"65","author":"A Dibra","year":"2005","unstructured":"Dibra A, Kastrati A, Mehilli J, Pache J, von Oepen R, Dirschinger J et al (2005) Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: a randomized double-blind controlled trial. Catheter Cardiovasc Interv 65:374\u2013380","journal-title":"Catheter Cardiovasc Interv"},{"key":"1328_CR23","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJMoa012843","volume":"346","author":"MC Morice","year":"2002","unstructured":"Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773\u20131780","journal-title":"N Engl J Med"},{"key":"1328_CR24","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1161\/01.CIR.0000127110.49192.72","volume":"109","author":"GW Stone","year":"2004","unstructured":"Stone GW, Ellis SG, Cox DA, Hermiller J, O\u2019Shaughnessy C, Mann JT et al (2004) One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 109:1942\u20131947","journal-title":"Circulation"},{"key":"1328_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193\u2013202","journal-title":"J Am Coll Cardiol"},{"key":"1328_CR26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","volume":"370","author":"C Stettler","year":"2007","unstructured":"Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A et al (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370:937\u2013948","journal-title":"Lancet"},{"key":"1328_CR27","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/01.ATV.0000157579.52566.ee","volume":"25","author":"R Wessely","year":"2005","unstructured":"Wessely R, Hausleiter J, Michaelis C, Jaschke B, Vogeser M, Milz S et al (2005) Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Arterioscler Thromb Vasc Biol 25:748\u2013753","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1328_CR28","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/eurheartj\/ehi405","volume":"26","author":"J Hausleiter","year":"2005","unstructured":"Hausleiter J, Kastrati A, Wessely R, Dibra A, Mehilli J, Schratzenstaller T et al (2005) Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating. Eur Heart J 26:1475\u20131481","journal-title":"Eur Heart J"},{"key":"1328_CR29","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1093\/eurheartj\/ehn253","volume":"29","author":"J Mehilli","year":"2008","unstructured":"Mehilli J, Byrne RA, Wieczorek A, Iijima R, Schulz S, Bruskina O et al (2008) Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. Eur Heart J 29:1975\u20131982","journal-title":"Eur Heart J"},{"key":"1328_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.jcin.2010.11.016","volume":"4","author":"S Desch","year":"2011","unstructured":"Desch S, Schloma D, Mobius-Winkler S, Erbs S, Gielen S, Linke A et al (2011) Randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus: the LIPSIA Yukon trial. JACC Cardiovasc Interv 4:452\u2013459","journal-title":"JACC Cardiovasc Interv"},{"key":"1328_CR31","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.biomaterials.2008.10.005","volume":"30","author":"K Steigerwald","year":"2009","unstructured":"Steigerwald K, Merl S, Kastrati A, Wieczorek A, Vorpahl M, Mannhold R et al (2009) The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts. Biomaterials 30:632\u2013637","journal-title":"Biomaterials"},{"key":"1328_CR32","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1093\/eurheartj\/ehp352","volume":"30","author":"RA Byrne","year":"2009","unstructured":"Byrne RA, Kastrati A, Kufner S, Massberg S, Birkmeier KA, Laugwitz KL et al (2009) Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial. Eur Heart J 30:2441\u20132449","journal-title":"Eur Heart J"},{"key":"1328_CR33","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.4244\/EIJY14M11_02","volume":"11","author":"S Kufner","year":"2016","unstructured":"Kufner S, Byrne RA, Valeskini M, Schulz S, Ibrahim T, Hoppmann P et al (2016) Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial. EuroIntervention 11:1372\u20131379","journal-title":"EuroIntervention"},{"key":"1328_CR34","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(08)61244-1","volume":"372","author":"S Windecker","year":"2008","unstructured":"Windecker S, Serruys PW, Wandel S, Buszman P, Trznadel S, Linke A et al (2008) Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 372:1163\u20131173","journal-title":"Lancet"},{"key":"1328_CR35","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/S0140-6736(11)61672-3","volume":"378","author":"GG Stefanini","year":"2011","unstructured":"Stefanini GG, Kalesan B, Serruys PW, Heg D, Buszman P, Linke A et al (2011) Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet 378:1940\u20131948","journal-title":"Lancet"},{"key":"1328_CR36","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1093\/eurheartj\/ehs086","volume":"33","author":"GG Stefanini","year":"2012","unstructured":"Stefanini GG, Byrne RA, Serruys PW, de Waha A, Meier B, Massberg S et al (2012) Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. Eur Heart J 33:1214\u20131222","journal-title":"Eur Heart J"},{"key":"1328_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJM199708073370601","volume":"337","author":"JC Tardif","year":"1997","unstructured":"Tardif JC, Cote G, Lesperance J, Bourassa M, Lambert J, Doucet S et al (1997) Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. N Engl J Med 337:365\u2013372","journal-title":"N Engl J Med"},{"key":"1328_CR38","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.111.026732","volume":"124","author":"S Massberg","year":"2011","unstructured":"Massberg S, Byrne RA, Kastrati A, Schulz S, Pache J, Hausleiter J et al (2011) Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial. Circulation 124:624\u2013632","journal-title":"Circulation"},{"key":"1328_CR39","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jcin.2016.01.009","volume":"9","author":"S Kufner","year":"2016","unstructured":"Kufner S, Sorges J, Mehilli J, Cassese S, Repp J, Wiebe J et al (2016) Randomized trial of polymer-free sirolimus- and probucol-eluting stents versus durable polymer zotarolimus-eluting stents: 5-year results of the ISAR-TEST-5 Trial. JACC Cardiovasc Interv 9:784\u2013792","journal-title":"JACC Cardiovasc Interv"},{"key":"1328_CR40","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1093\/eurheartj\/ehv203","volume":"36","author":"RA Byrne","year":"2015","unstructured":"Byrne RA, Serruys PW, Baumbach A, Escaned J, Fajadet J, James S et al (2015) Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary. Eur Heart J 36:2608\u20132620","journal-title":"Eur Heart J"},{"key":"1328_CR41","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0735-1097(97)00334-3","volume":"30","author":"A Kastrati","year":"1997","unstructured":"Kastrati A, Schomig A, Elezi S, Schuhlen H, Dirschinger J, Hadamitzky M et al (1997) Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30:1428\u20131436","journal-title":"J Am Coll Cardiol"},{"key":"1328_CR42","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/S0002-9149(99)00165-4","volume":"83","author":"A Kastrati","year":"1999","unstructured":"Kastrati A, Elezi S, Dirschinger J, Hadamitzky M, Neumann FJ, Schomig A (1999) Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 83:1617\u20131622","journal-title":"Am J Cardiol"},{"key":"1328_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/heartjnl-2013-304933","volume":"100","author":"S Cassese","year":"2014","unstructured":"Cassese S, Byrne RA, Tada T, Pinieck S, Joner M, Ibrahim T et al (2014) Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart 100:153\u2013159","journal-title":"Heart"},{"key":"1328_CR44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/eurheartj\/ehu383","volume":"36","author":"S Cassese","year":"2015","unstructured":"Cassese S, Byrne RA, Schulz S, Hoppman P, Kreutzer J, Feuchtenberger A et al (2015) Prognostic role of restenosis in 10,004 patients undergoing routine control angiography after coronary stenting. Eur Heart J 36:94\u201399","journal-title":"Eur Heart J"},{"key":"1328_CR45","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0735-1097(03)01056-8","volume":"42","author":"B Scheller","year":"2003","unstructured":"Scheller B, Speck U, Schmitt A, Bohm M, Nickenig G (2003) Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J Am Coll Cardiol 42:1415\u20131420","journal-title":"J Am Coll Cardiol"},{"key":"1328_CR46","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/S0195-668X(03)00317-8","volume":"24","author":"B Scheller","year":"2003","unstructured":"Scheller B, Speck U, Romeike B, Schmitt A, Sovak M, Bohm M et al (2003) Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur Heart J 24:1462\u20131467","journal-title":"Eur Heart J"},{"key":"1328_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/01.rli.0000116125.96544.64","volume":"39","author":"U Speck","year":"2004","unstructured":"Speck U, Scheller B, Abramjuk C, Grossmann S, Mahnkopf D, Simon O (2004) Inhibition of restenosis in stented porcine coronary arteries: uptake of paclitaxel from angiographic contrast media. Investig Radiol 39:182\u2013186","journal-title":"Investig Radiol"},{"key":"1328_CR48","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/01.CIR.0000138929.71660.E0","volume":"110","author":"B Scheller","year":"2004","unstructured":"Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G (2004) Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110:810\u2013814","journal-title":"Circulation"},{"key":"1328_CR49","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMoa061254","volume":"355","author":"B Scheller","year":"2006","unstructured":"Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U et al (2006) Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 355:2113\u20132124","journal-title":"N Engl J Med"},{"key":"1328_CR50","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","volume":"381","author":"RA Byrne","year":"2013","unstructured":"Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K et al (2013) Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 381:461\u2013467","journal-title":"Lancet"},{"key":"1328_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","volume":"66","author":"F Alfonso","year":"2015","unstructured":"Alfonso F, Perez-Vizcayno MJ, Cardenas A, Garcia del B, Blanco A, Garcia-Touchard JR, Lopez-Minguez et al (2015) A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial. J Am Coll Cardiol 66:23\u201333","journal-title":"J Am Coll Cardiol"},{"key":"1328_CR52","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0140-6736(15)60657-2","volume":"386","author":"GC Siontis","year":"2015","unstructured":"Siontis GC, Stefanini GG, Mavridis D, Siontis KC, Alfonso F, Perez-Vizcayno MJ et al (2015) Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis. Lancet 386:655\u2013664","journal-title":"Lancet"},{"key":"1328_CR53","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"S Windecker","year":"2014","unstructured":"Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V et al (2014) 2014 ESC\/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541\u20132619","journal-title":"Eur Heart J"},{"key":"1328_CR54","doi-asserted-by":"publisher","first-page":"613621","DOI":"10.1007\/s00392-015-0957-6","volume":"105","author":"FX Kleber","year":"2016","unstructured":"Kleber FX, Rittger H, Ludwig J, Schulz A, Mathey DG, Boxberger M et al (2016) Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial. Clin Res Cardiol 105:613\u2013621","journal-title":"Clin Res Cardiol"},{"key":"1328_CR55","first-page":"2128","volume":"35","author":"T Adriaenssens","year":"2014","unstructured":"Adriaenssens T, Byrne R (2014) PREvention of late Stent Thrombosis by an Interdisciplinary Global European effort: PRESTIGE. Eur Heart J 35:2128\u20132129","journal-title":"Eur Heart J"},{"key":"1328_CR56","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/CIRCULATIONAHA.117.026788","volume":"136","author":"T Adriaenssens","year":"2017","unstructured":"Adriaenssens T, Joner M, Godschalk TC, Malik N, Alfonso F, Xhepa E et al (2017) Optical coherence tomography findings in patients with coronary stent thrombosis: a Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort). Circulation 136:1007\u20131021","journal-title":"Circulation"},{"key":"1328_CR57","first-page":"537544","volume":"387","author":"S Cassese","year":"2015","unstructured":"Cassese S, Byrne RA, Ndrepepa G, Kufner S, Wiebe J, Repp J et al (2015) Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. Lancet 387:537\u2013544","journal-title":"Lancet"},{"key":"1328_CR58","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0140-6736(17)31470-8","volume":"390","author":"ZA Ali","year":"2017","unstructured":"Ali ZA, Serruys PW, Kimura T, Gao R, Ellis SG, Kereiakes DJ et al (2017) 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Lancet 390:760\u2013772","journal-title":"Lancet"},{"key":"1328_CR59","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1016\/j.jacc.2017.10.010","volume":"70","author":"DJ Kereiakes","year":"2017","unstructured":"Kereiakes DJ, Ellis SG, Metzger C, Caputo RP, Rizik DG, Teirstein PS et al (2017) 3-Year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III Trial. J Am Coll Cardiol 70:2852\u20132862","journal-title":"J Am Coll Cardiol"},{"key":"1328_CR60","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","volume":"388","author":"PW Serruys","year":"2016","unstructured":"Serruys PW, Chevalier B, Sotomi Y, Cequier A, Carrie D, Piek JJ et al (2016) Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet 388:2479\u20132491","journal-title":"Lancet"},{"key":"1328_CR61","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","volume":"376","author":"JJ Wykrzykowska","year":"2017","unstructured":"Wykrzykowska JJ, Kraak RP, Hofma SH, van der Schaaf RJ, Arkenbout EK, IJsselmuiden AJ et al (2017) Bioresorbable scaffolds versus metallic stents in routine PCI. N Engl J Med 376:2319\u20132328","journal-title":"N Engl J Med"},{"issue":"Suppl V)","key":"1328_CR62","first-page":"V159V165","volume":"11","author":"OD Sanchez","year":"2015","unstructured":"Sanchez OD, Yahagi K, Byrne RA, Mori H, Zarpak R, Wittchow E et al (2015) Pathological aspects of bioresorbable stent implantation. EuroIntervention 11(Suppl V):V159\u2013V165","journal-title":"EuroIntervention"},{"key":"1328_CR63","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.jacc.2015.08.853","volume":"66","author":"L Raber","year":"2015","unstructured":"Raber L, Brugaletta S, Yamaji K, O\u2019Sullivan CJ, Otsuki S, Koppara T et al (2015) Very late scaffold thrombosis: intracoronary imaging and histopathological and spectroscopic findings. J Am Coll Cardiol 66:1901\u20131914","journal-title":"J Am Coll Cardiol"},{"key":"1328_CR64","doi-asserted-by":"publisher","first-page":"828","DOI":"10.4244\/EIJV12I7A137","volume":"12","author":"J Fajadet","year":"2016","unstructured":"Fajadet J, Haude M, Joner M, Koolen J, Lee M, Tolg R et al (2016) Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016. EuroIntervention 12:828\u2013833","journal-title":"EuroIntervention"},{"key":"1328_CR65","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/S0140-6736(07)60853-8","volume":"369","author":"R Erbel","year":"2007","unstructured":"Erbel R, Mario CD, Bartunek J, Bonnier J, de Bruyne B, Eberli FR et al (2007) Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 369:1869\u20131875","journal-title":"Lancet"},{"key":"1328_CR66","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0140-6736(12)61765-6","volume":"381","author":"M Haude","year":"2013","unstructured":"Haude M, Erbel R, Erne P, Verheye S, Degen H, Bose D et al (2013) Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. Lancet 381:836\u2013844","journal-title":"Lancet"},{"key":"1328_CR67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)00447-X","volume":"387","author":"M Haude","year":"2016","unstructured":"Haude M, Ince H, Abizaid A, Toelg R, Lemos PA, von Birgelen C et al (2016) Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. Lancet 387:31\u201339","journal-title":"Lancet"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-018-1328-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1328-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1328-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T19:09:29Z","timestamp":1563822569000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-018-1328-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,23]]},"references-count":67,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1328"],"URL":"https:\/\/doi.org\/10.1007\/s00392-018-1328-x","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,23]]},"assertion":[{"value":"24 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}